ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TailorCare Releases 2025 Year-End Results Showing Significant MSK Improvements and Lower Costs

Nashville, TN, Dec. 11, 2025 (GLOBE NEWSWIRE) -- TailorCare, a leading provider of value-based specialty musculoskeletal (MSK) care solutions accessible to more than 2.5 million eligible Medicare Advantage (MA) and commercial members, today released its 2025 Year-End Review highlighting continued improvements in MSK outcomes, patient experience, and total cost of care. This comes at a time when joint, back, and muscle pain affects 50% of U.S. adults and drives more than $420 billion in annual healthcare spending.

2025 Momentum and Expansion

TailorCare strengthened its national footprint and expanded access to earlier, personalized MSK navigation through key initiatives:

  • Integrated RecoveryOne, adding virtual physical therapy (PT) and digital MSK recovery tools.
  • Expanded Humana MA partnerships into Dallas and Denver.
  • Acquired computer vision technology Stabl to enhance MSK recovery at home.
  • Formed AI Advisory Board to advance Value-Based Care innovation.
  • Delivered navigation and virtual PT solutions across all 50 states.

TailorCare also completed roughly 12,000 PT-led structured evaluations this year, ensuring consistent, clinically rigorous guidance at scale.

Improved Outcomes for MSK Patients

TailorCare’s personalized, conservative-first model continues to deliver strong results across diverse patient populations:

  • 90% improved in pain or function
  • 87% adhered to evidence-based conservative care
  • 77% fewer surgical prior authorization denials
  • 4.7/5.0 average patient rating

TailorCare’s investments of AI and data science, coupled with its proprietary datasets, have enabled the identification of up to 87% of high-priority MSK members at risk of avoidable surgery months in advance, resulting in earlier intervention for more optimal outcomes.

Lower Costs and Reduced Surgical Burden

TailorCare helped reduce unnecessary care and overall MSK spending:

  • 40% lower medical costs for PT-adherent MA members
  • 14% reduction in out-of-pocket surgical expenses
  • 70% reduction in skilled nursing facility admissions
  • Meaningful declines across several high-cost surgical categories 

A More Personal MSK Experience

Cheryl, 66, loved her daily walks until hip pain made even simple movement difficult. After being told surgery was her only option, she turned to TailorCare. A Clinical Navigator helped her understand her condition, schedule PT, and stay supported through recovery. Within weeks, Cheryl returned to her daily activities and felt stronger mentally and physically.

“I feel 100% better than I did a year ago today,” said Cheryl.

“Patients aren’t looking for more procedures, they’re looking for relief,” said Rachel Winokur, founder and CEO of TailorCare. “Cheryl’s story shows how early engagement and personalized PT-led support create safer, more effective paths to feeling better. We’re looking forward to serving even more Humana MA members like Cheryl in Georgia and Texas.”

Link to Patient Story

Looking Ahead

In 2026, TailorCare will build on the momentum highlighted in its 2024–2025 Impact Report to expand full-risk MSK programs into new states and health plan partnerships. Central to this growth is the company's proprietary predictive modeling and AI-driven automation, which enhance clinical precision and the personalization of the patient care journey. With these technologies, TailorCare will continue to improve its program capabilities to engage patients earlier, deliver better clinical outcomes, and reduce avoidable MSK spend, ensuring more patients receive the right care at the right time.

Link to 2024-2025 Impact Report

About TailorCare
TailorCare is a leading provider of specialty value-based care solutions focused on improving patient outcomes for joint, back, and muscle conditions. We take a deeply personal, data-driven approach by carefully assessing patients’ symptoms, health history, preferences, and goals for musculoskeletal health improvement. Utilizing predictive data analytics and AI paired with proprietary datasets and the latest evidence-based guidelines, we guide patients in navigating the most effective treatment pathways every step of the way. Learn more at www.tailorcare.com and follow us on LinkedIn at @TailorCare.


Melanie Hill
TailorCare
media@tailorcare.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.19
-4.09 (-1.78%)
AAPL  278.28
+0.25 (0.09%)
AMD  210.80
-10.63 (-4.80%)
BAC  55.14
+0.58 (1.06%)
GOOG  310.52
-3.18 (-1.01%)
META  644.23
-8.48 (-1.30%)
MSFT  478.53
-4.94 (-1.02%)
NVDA  175.02
-5.91 (-3.27%)
ORCL  189.97
-8.88 (-4.47%)
TSLA  459.16
+12.27 (2.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.